Escalon Medical (OTCMKTS:ESMC) and Magna-Lab (OTCMKTS:MAGAA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.
This table compares Escalon Medical and Magna-Lab’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Escalon Medical has a beta of -0.64, meaning that its share price is 164% less volatile than the S&P 500. Comparatively, Magna-Lab has a beta of 17.24, meaning that its share price is 1,624% more volatile than the S&P 500.
This is a summary of recent ratings and price targets for Escalon Medical and Magna-Lab, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Insider & Institutional Ownership
0.1% of Escalon Medical shares are held by institutional investors. 1.9% of Escalon Medical shares are held by company insiders. Comparatively, 15.3% of Magna-Lab shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Escalon Medical and Magna-Lab’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Escalon Medical||$11.40 million||0.11||$580,000.00||N/A||N/A|
Escalon Medical has higher revenue and earnings than Magna-Lab.
Escalon Medical beats Magna-Lab on 6 of the 8 factors compared between the two stocks.
Escalon Medical Company Profile
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States, Europe, and Asia. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products primarily to teaching institutions, hospitals, and eye surgery centers through independent sales representatives. Escalon Medical Corp. was founded in 1987 and is based in Wayne, Pennsylvania.
Magna-Lab Company Profile
Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. Magna-Lab Inc. was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.
Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.